
Farley J. Abad
Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )
| Most Active Art Unit | 2181 |
| Art Unit(s) | 2181 |
| Total Applications | 1076 |
| Issued Applications | 864 |
| Pending Applications | 101 |
| Abandoned Applications | 140 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4676120
[patent_doc_number] => 20080213750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'HCV Variants and Related Methods'
[patent_app_type] => utility
[patent_app_number] => 11/960391
[patent_app_country] => US
[patent_app_date] => 2007-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 31504
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213750.pdf
[firstpage_image] =>[orig_patent_app_number] => 11960391
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/960391 | Cell lines permissive for HCV replication | Dec 18, 2007 | Issued |
Array
(
[id] => 263611
[patent_doc_number] => 07569374
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-04
[patent_title] => 'HCV RNA-dependent RNA polymerase'
[patent_app_type] => utility
[patent_app_number] => 12/002392
[patent_app_country] => US
[patent_app_date] => 2007-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 4546
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/569/07569374.pdf
[firstpage_image] =>[orig_patent_app_number] => 12002392
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/002392 | HCV RNA-dependent RNA polymerase | Dec 16, 2007 | Issued |
Array
(
[id] => 6588160
[patent_doc_number] => 20100291542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'RAPID IMMUNOCHROMATOGRAPHIC DETECTION BY AMPLIFICATION OF THE COLLOIDAL GOLD SIGNAL'
[patent_app_type] => utility
[patent_app_number] => 12/518756
[patent_app_country] => US
[patent_app_date] => 2007-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6005
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291542.pdf
[firstpage_image] =>[orig_patent_app_number] => 12518756
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/518756 | RAPID IMMUNOCHROMATOGRAPHIC DETECTION BY AMPLIFICATION OF THE COLLOIDAL GOLD SIGNAL | Dec 5, 2007 | Abandoned |
Array
(
[id] => 12771
[patent_doc_number] => 07807173
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Influenza vaccine formulation'
[patent_app_type] => utility
[patent_app_number] => 11/948505
[patent_app_country] => US
[patent_app_date] => 2007-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 22
[patent_no_of_words] => 7854
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807173.pdf
[firstpage_image] =>[orig_patent_app_number] => 11948505
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/948505 | Influenza vaccine formulation | Nov 29, 2007 | Issued |
Array
(
[id] => 6478576
[patent_doc_number] => 20100285106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'MULTICOMPONENT VACCINE'
[patent_app_type] => utility
[patent_app_number] => 12/312587
[patent_app_country] => US
[patent_app_date] => 2007-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 11117
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20100285106.pdf
[firstpage_image] =>[orig_patent_app_number] => 12312587
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/312587 | MULTICOMPONENT VACCINE | Nov 18, 2007 | Abandoned |
Array
(
[id] => 5575001
[patent_doc_number] => 20090142362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP)'
[patent_app_type] => utility
[patent_app_number] => 11/983039
[patent_app_country] => US
[patent_app_date] => 2007-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22955
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20090142362.pdf
[firstpage_image] =>[orig_patent_app_number] => 11983039
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/983039 | Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP) | Nov 5, 2007 | Abandoned |
Array
(
[id] => 102659
[patent_doc_number] => 07728121
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-01
[patent_title] => 'Hepatitis-C virus type 4, 5 and 6'
[patent_app_type] => utility
[patent_app_number] => 11/933672
[patent_app_country] => US
[patent_app_date] => 2007-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12096
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/728/07728121.pdf
[firstpage_image] =>[orig_patent_app_number] => 11933672
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/933672 | Hepatitis-C virus type 4, 5 and 6 | Oct 31, 2007 | Issued |
Array
(
[id] => 4715383
[patent_doc_number] => 20080237905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Preparation of polyphosphazene microspheres'
[patent_app_type] => utility
[patent_app_number] => 11/982028
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3245
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20080237905.pdf
[firstpage_image] =>[orig_patent_app_number] => 11982028
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/982028 | Preparation of polyphosphazene microspheres | Oct 30, 2007 | Abandoned |
Array
(
[id] => 5336737
[patent_doc_number] => 20090053201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'HEPATITIS B VIRAL VARIANTS WITH REDUCED SUSCEPTIBILITY TO NUCLEOSIDE ANALOGS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/932714
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 36115
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053201.pdf
[firstpage_image] =>[orig_patent_app_number] => 11932714
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/932714 | Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof | Oct 30, 2007 | Issued |
Array
(
[id] => 5436366
[patent_doc_number] => 20090170953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'INDENTIFICATION OF COMPOUNDS THAT INHIBIT REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS'
[patent_app_type] => utility
[patent_app_number] => 11/929695
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 29185
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170953.pdf
[firstpage_image] =>[orig_patent_app_number] => 11929695
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/929695 | INDENTIFICATION OF COMPOUNDS THAT INHIBIT REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS | Oct 29, 2007 | Abandoned |
Array
(
[id] => 5490813
[patent_doc_number] => 20090291884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'Proteins for use in diagnosing and treating infection and disease'
[patent_app_type] => utility
[patent_app_number] => 11/973920
[patent_app_country] => US
[patent_app_date] => 2007-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4933
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20090291884.pdf
[firstpage_image] =>[orig_patent_app_number] => 11973920
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/973920 | Proteins for use in diagnosing and treating infection and disease | Oct 10, 2007 | Abandoned |
Array
(
[id] => 4698226
[patent_doc_number] => 20080220410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'METHOD FOR REPLICATING THE HEPATITIS C VIRUS'
[patent_app_type] => utility
[patent_app_number] => 11/865954
[patent_app_country] => US
[patent_app_date] => 2007-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14097
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20080220410.pdf
[firstpage_image] =>[orig_patent_app_number] => 11865954
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/865954 | Nucleotide sequences coding for the non-structural proteins of the hepatitis C virus | Oct 1, 2007 | Issued |
Array
(
[id] => 4825743
[patent_doc_number] => 20080124763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Constructs and methods for expression of recombinant proteins in methylotrophic yeast cells'
[patent_app_type] => utility
[patent_app_number] => 11/902807
[patent_app_country] => US
[patent_app_date] => 2007-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 40067
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20080124763.pdf
[firstpage_image] =>[orig_patent_app_number] => 11902807
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/902807 | Constructs and methods for expression of recombinant proteins in methylotrophic yeast cells | Sep 24, 2007 | Abandoned |
Array
(
[id] => 81190
[patent_doc_number] => 07745130
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-29
[patent_title] => 'Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/860727
[patent_app_country] => US
[patent_app_date] => 2007-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 33
[patent_no_of_words] => 36030
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/745/07745130.pdf
[firstpage_image] =>[orig_patent_app_number] => 11860727
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/860727 | Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof | Sep 24, 2007 | Issued |
Array
(
[id] => 159005
[patent_doc_number] => 07674578
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-09
[patent_title] => 'Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy'
[patent_app_type] => utility
[patent_app_number] => 11/855238
[patent_app_country] => US
[patent_app_date] => 2007-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 4184
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/674/07674578.pdf
[firstpage_image] =>[orig_patent_app_number] => 11855238
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/855238 | Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy | Sep 13, 2007 | Issued |
Array
(
[id] => 4785465
[patent_doc_number] => 20080138794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Method for detecting or measuring HBV'
[patent_app_type] => utility
[patent_app_number] => 11/898419
[patent_app_country] => US
[patent_app_date] => 2007-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9699
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20080138794.pdf
[firstpage_image] =>[orig_patent_app_number] => 11898419
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/898419 | Method for detecting or measuring HBV | Sep 11, 2007 | Abandoned |
Array
(
[id] => 5416294
[patent_doc_number] => 20090042181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene'
[patent_app_type] => utility
[patent_app_number] => 11/898468
[patent_app_country] => US
[patent_app_date] => 2007-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9688
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20090042181.pdf
[firstpage_image] =>[orig_patent_app_number] => 11898468
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/898468 | Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene | Sep 11, 2007 | Issued |
Array
(
[id] => 5452598
[patent_doc_number] => 20090068635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'INDIRECTLY LABELLED ASSAY CONJUGATES AND METHODS OF PREPARING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 11/851050
[patent_app_country] => US
[patent_app_date] => 2007-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14245
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20090068635.pdf
[firstpage_image] =>[orig_patent_app_number] => 11851050
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/851050 | INDIRECTLY LABELLED ASSAY CONJUGATES AND METHODS OF PREPARING AND USING SAME | Sep 5, 2007 | Abandoned |
Array
(
[id] => 4676840
[patent_doc_number] => 20080214471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Method for inhibition of viral infection'
[patent_app_type] => utility
[patent_app_number] => 11/894365
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10700
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214471.pdf
[firstpage_image] =>[orig_patent_app_number] => 11894365
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/894365 | Method for inhibition of viral infection | Aug 19, 2007 | Abandoned |
Array
(
[id] => 4866323
[patent_doc_number] => 20080145382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'RECOMBINANT VIRUS EXPRESSING FOREIGN DNA ENCODING FELINE CD80, FELINE CD86, FELINE CD28, OR FELINE CTLA-4 AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/840708
[patent_app_country] => US
[patent_app_date] => 2007-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 46887
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145382.pdf
[firstpage_image] =>[orig_patent_app_number] => 11840708
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/840708 | RECOMBINANT VIRUS EXPRESSING FOREIGN DNA ENCODING FELINE CD80, FELINE CD86, FELINE CD28, OR FELINE CTLA-4 AND USES THEREOF | Aug 16, 2007 | Abandoned |